A Relative Bioavailability Study of Oxycodone 5 mg / Ibuprofen 400 mg Tablets Under Non-fasting Conditions
Status:
Completed
Trial end date:
2006-10-01
Target enrollment:
Participant gender:
Summary
To compare the relative bioavailability of oxycodone HCl 5 mg / ibuprofen 400 mg tablets
(Actavis Elizabeth LLC, Lot No. PI-1565) with that of COMBONOX® tablets (Forest
Pharmaceuticals, Inc., Lot No. 010550) in healthy adult volunteers under non-fasting
conditions.